Analyst Consensus ?
ConsensusHold23 ratings
Bullish626.1%
Neutral1565.2%
Bearish28.7%
FN2 Earnings Intelligence
Rollins, Inc. complete analyst coverage
Rollins, Inc. (ROL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$33.99Current
$27Low
$48.05Average
$72High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Underweight | Underweight | Maintain | Oct 23, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 23, 2026 |
| Canaccord Genuity | Hold | Hold | Maintain | Oct 23, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Oct 19, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 15, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 13, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 13, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Sep 29, 2026 |
| Piper Sandler | Neutral | Overweight | Downgrade | Sep 24, 2026 |
| Argus Research | Hold | Buy | Downgrade | Aug 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 24, 2026 |
| RBC Capital | Sector Perform | Outperform | Downgrade | Jul 23, 2026 |
| B of A Securities | Underperform | Buy | Downgrade | Jul 23, 2026 |
| Jefferies | Buy | Hold | Upgrade | Jun 2, 2025 |
| Stifel | Buy | Hold | Upgrade | Oct 20, 2023 |
| Buckingham Research | Neutral | Neutral | Maintain | Feb 4, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Feb 4, 2020 |
| Stifel Nicolaus | Hold | Sell | Upgrade | Nov 6, 2019 |
| Nomura | Buy | Buy | Maintain | Apr 30, 2019 |
| Macquarie | Neutral | Neutral | Maintain | Apr 30, 2019 |
| William Blair | Outperform | Outperform | Maintain | Jan 30, 2018 |
| Sidoti & Co. | Neutral | Buy | Downgrade | Mar 21, 2016 |
| KeyBanc | Hold | Hold | Maintain | Apr 17, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $33.99. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Canaccord Genuity | Analyst unavailable | $33 | $35.31 | -2.9% | Oct 23, 2026 |
| Goldman Sachs | Analyst unavailable | $42 | $35.31 | +23.6% | Oct 22, 2026 |
| Canaccord Genuity | Brian McNamara | $36 | $32.83 | +5.9% | Oct 19, 2026 |
| Bernstein | Connor Cerniglia | $35 | $33.45 | +3.0% | Oct 19, 2026 |
| UBS | Analyst unavailable | $36 | $32.15 | +5.9% | Oct 14, 2026 |
| Wells Fargo | Jason Hass | $27 | $30.59 | -20.6% | Sep 29, 2026 |
| Piper Sandler | Analyst unavailable | $33 | $32.49 | -2.9% | Sep 23, 2026 |
| UBS | Joshua Chan | $43 | $38.59 | +26.5% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $45 | $39.44 | +32.4% | Jul 24, 2026 |
| Wells Fargo | Jason Haas | $32 | $39.44 | -5.9% | Jul 24, 2026 |
| Canaccord Genuity | Analyst unavailable | $45 | $38.62 | +32.4% | Jul 23, 2026 |
| Raymond James | Analyst unavailable | $35 | $43.47 | +3.0% | Jul 23, 2026 |
| RBC Capital | Ashish Sabadra | $40 | $43.47 | +17.7% | Jul 23, 2026 |
| UBS | Analyst unavailable | $50 | $44.29 | +47.1% | Jul 15, 2026 |
| Morgan Stanley | Greg Parrish | $65 | $43.62 | +91.2% | Jul 8, 2026 |
| Wells Fargo | Analyst unavailable | $46 | $44.54 | +35.3% | Jun 25, 2026 |
| Bernstein | Connor Cerniglia | $52 | $49.42 | +53.0% | May 29, 2026 |
| Redburn Partners | Analyst unavailable | $66 | $56.6 | +94.2% | Apr 27, 2026 |
| UBS | Analyst unavailable | $61 | $56.16 | +79.5% | Apr 24, 2026 |
| Canaccord Genuity | Analyst unavailable | $51 | $56.99 | +50.0% | Apr 24, 2026 |
| Goldman Sachs | Analyst unavailable | $67 | $56.99 | +97.1% | Apr 23, 2026 |
| UBS | Analyst unavailable | $58 | $54.8 | +70.6% | Apr 10, 2026 |
| Morgan Stanley | Analyst unavailable | $70 | $58.97 | +105.9% | Feb 13, 2026 |
| Canaccord Genuity | Analyst unavailable | $52 | $58.69 | +53.0% | Feb 13, 2026 |
| RBC Capital | Analyst unavailable | $67 | $57.07 | +97.1% | Feb 12, 2026 |
| Wells Fargo | Jason Haas | $56 | $65.6 | +64.8% | Feb 12, 2026 |
| UBS | Analyst unavailable | $65 | $63.11 | +91.2% | Jan 21, 2026 |
| RBC Capital | Ashish Sabadra | $70 | $60.71 | +105.9% | Dec 23, 2025 |
| Morgan Stanley | Toni Kaplan | $72 | $59.46 | +111.8% | Dec 17, 2025 |
| Barclays | Analyst unavailable | $72 | $60.34 | +111.8% | Dec 5, 2025 |
| Jefferies | Stephanie Moore | $66 | $57.61 | +94.2% | Nov 3, 2025 |
| Canaccord Genuity | Analyst unavailable | $55 | $57.79 | +61.8% | Oct 31, 2025 |
| Goldman Sachs | George Tong | $64 | $57.79 | +88.3% | Oct 30, 2025 |
| Wells Fargo | Analyst unavailable | $63 | $56.28 | +85.3% | Oct 28, 2025 |
| Goldman Sachs | George Tong | $61 | $55.47 | +79.5% | Apr 24, 2025 |
| Barclays | Analyst unavailable | $55 | $52.21 | +61.8% | Apr 4, 2025 |
| Barclays | Manav Patnaik | $50 | $47.86 | +47.1% | Nov 4, 2024 |
| Wells Fargo | Jason Haas | $54 | $47.78 | +58.9% | Aug 12, 2024 |
| Stifel Nicolaus | Michael Hoffman | $54 | $49.75 | +58.9% | Jun 20, 2024 |
| UBS | Joshua Chan | $49 | $44.35 | +44.2% | Apr 15, 2024 |
| RBC Capital | Ashish Sabadra | $52 | $43.8 | +53.0% | Jul 13, 2023 |
Track every rating change on ROL the moment it posts. Free to start.
Start freeGet the ROL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.